CIBC Asset Management Inc - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$280,018
+5.9%
2,3100.0%0.00%0.0%
Q2 2023$264,541
-16.9%
2,3100.0%0.00%0.0%
Q1 2023$318,387
+8.7%
2,310
+2.2%
0.00%0.0%
Q4 2022$292,980
-97.9%
2,261
-98.2%
0.00%
-98.4%
Q3 2022$14,036,000
+6110.6%
126,975
+4112.8%
0.06%
+6100.0%
Q2 2022$226,000
-98.5%
3,014
-98.5%
0.00%
-98.1%
Q1 2022$15,387,000
-13.2%
196,9690.0%0.05%
-16.9%
Q4 2021$17,737,000
-37.1%
196,969
-35.4%
0.06%
-43.0%
Q3 2021$28,219,000
+32.3%
305,131
+11.2%
0.11%
+32.6%
Q2 2021$21,330,000
+9729.5%
274,380
+9315.9%
0.09%
+8500.0%
Q1 2021$217,000
-54.5%
2,914
+4.2%
0.00%
-50.0%
Q4 2020$477,000
+21.4%
2,7960.0%0.00%0.0%
Q3 2020$393,000
-10.1%
2,796
+2.5%
0.00%
-33.3%
Q2 2020$437,000
+63.7%
2,7270.0%0.00%
+50.0%
Q1 2020$267,000
-24.1%
2,7270.0%0.00%0.0%
Q4 2019$352,0000.0%2,727
+17.7%
0.00%0.0%
Q2 2019$352,000
+27.5%
2,3170.0%0.00%0.0%
Q1 2019$276,000
+9.1%
2,3170.0%0.00%0.0%
Q4 2018$253,000
-32.4%
2,3170.0%0.00%0.0%
Q3 2018$374,000
+22.2%
2,3170.0%0.00%0.0%
Q2 2018$306,0002,3170.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders